VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 8139 · 116th Congress

SUPPLIES Act of 2020

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

1 cosponsor · 1 D

1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020 or the SUPPLIES Act of 2020

What it does: CRS summary · Introduced in House · Sep 1, 2020

Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020 or the SUPPLIES Act of 2020

This bill excludes certain short-dated drugs from rebate calculations under the Medicaid Drug Rebate Program during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). Specifically, the bill excludes from such calculations direct sales of drugs that (1) have a shelf life of one year or more and expire one year after the date of sale, or (2) have a shelf life of less than one year and expire after the same number of days as the shelf life following the date of sale.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: SUPPLIES Act of 2020

Also known as: Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020

Latest action (Sep 1, 2020): Referred to the House Committee on Energy and Commerce.

Policy area: Health · Origin: House · Introduced: Sep 1, 2020

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.